iifl-logo

Goldline Pharmaceutical Ltd Auditor Reports

Add as a Preferred Source on Google
0
(0%)

Goldline Pharmaceutical Ltd Share Price Auditors Report

To,

The Board of Directors

Goldline Pharmaceutical Limited

103, F-1 Leela Apartments, Shilpa HSG Society,

Near Saptagiri Nagar, Shanidham, Narendra Nagar Nagpur, Maharashtra, India - 440015

Dear sir,

Reference- Proposed Public Issue of Equity Shares of Goldline Pharmaceutical Limited

1. We, M/s. B Shroff & Co., have examined the attached restated financial information of "Goldline Pharmaceutical Limited" (hereinafter referred to as "the Company" or "the Issuer") comprising the restated statement of assets and liabilities as at 31st March 2025, 31st March 2024, 31st March 2023 and, restated statement of Profit and Loss and restated Cash Flow statement for the financial year ended on 31st March 2025, 31st March 2024, and 31st March 2023 and the summary statement of significant accounting policies and other explanatory information (collectively referred to as the "Restated Financial Information" or "Restated Financial Statements") annexed to this report and initiated by us for identification purposes. These Restated Financial Statements have been prepared by the management of the Company and approved by the board of directors at their meeting in connection with the proposed Initial Public Offering on SME Platform ("IPO" or "SMEIPO") of Bombay Stock Exchange of India Limited ("BSE") of the company.

2. These restated summary statements have been prepared in accordance with the requirements of:

(i) Section 26 of Part - I of Chapter III of Companies Act, 2013 (the "Act") read with Companies (Prospectus and Allotment of Securities) Rules 2014;

(ii) The Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 ("ICDR Regulations") and related amendments/ clarifications from time to time issued by the Securities and Exchange Board of India ("SEBI");

(iii) The Guidance Note on Reports in Company Prospectuses (Revised 2019) issued by the Institute of Chartered Accountants of India ("Guidance Note")

3. The Company’s Board of Directors is responsible for the preparation of the Restated Financial Statements for inclusion in the prospectus to be filed with Securities and Exchange Board of India ("SEBI"), SME Platform of Bombay Stock Exchange of India Limited ("BSE") and Registrar of Companies Mumbai in connection with the proposed IPO. The Restated Financial Statements have been prepared by the management of the Company on the basis of preparation stated in Annexure 41 to the Restated Financial Statements. The responsibility of the board of directors of the Company includes designing, implementing and maintaining adequate internal control relevant to the preparation and presentation of the Restated Financial Statements. The Board of Directors is also responsible for identifying and ensuring that the Company complies with the Act, ICDR Regulations and the Guidance Note.

4. We have examined such Restated Financial Statements taking into consideration:

(i) The terms of reference and terms of our engagement agreed upon with you in accordance with our engagement letter in connection with the proposed SME IPO of equity share of the company; and

(ii) The Guidance Note also requires that we comply with the ethical requirements of the Code of Ethics issued by the ICAI;

(iii) Concepts of test checks and materiality to obtain reasonable assurance based on verification of evidence supporting the Restated Financial Statements;

(iv) The requirements of Section 26 of the Act and the ICDR Regulations. Our work was performed solely to assist you in meeting your responsibilities in relation to your compliance with the Act, the ICDR Regulations and the Guidance Note in connection with the IPO.

5. The Restated Financial Statements of the Company have been compiled by the management from:

(i) The audit for the year ended on 31st March 2025 and 31st March 2024 conducted by us & for the financial year ended on 31st March 2023 was conducted by M/s Shah & Raut Chartered Accountants Statutory Auditors. There are no material audit qualifications in the audit reports issued by the statutory and tax auditors for the financial year ended on 31st March 2025, 31st March 2024 and 31st March 2023 which would require adjustments in the Restated Financial Statements of the Company. The financial report included for these years is based solely on the report submitted by them.

(ii) We have Re-audited the Financial statements of the company in accordance with applicable standards as required under the SEBI ICDR regulations for the financial year ended on 31st March 2025, 31st March 2024 and 31st March 2023, prepared in accordance with the Indian Accounting Standards (Indian GAAP) which have been approved by the Board of Directors.

(iii) Based on our examination and according to information and explanations given to us, we are of the opinion that the Restated Financial Statements:

a) Have been prepared after incorporating adjustments for the changes in accounting policies, material errors and regrouping/ reclassifications retrospectively for the financial year ended on 31st March 2025, 31st March 2024, 31st March 2023.

b) do not require any adjustment for modification as there is no modification in the underlying audit reports;

c) there are no extra-ordinary items that need to be disclosed separately in the accounts and requiring adjustments.

d) have been prepared in accordance with the Act, ICDR Regulations and Guidance Note.

e) Adequate disclosure has been made in the financial statements as required to be made by the issuer as per schedule III of the Companies Act, 2013.

f) The accounting standards prescribed under the Companies act, 2013 have been followed.

g) The financial statements present a true and fair view of the company’s accounts.

h) In accordance with the requirements of the Act including the rules made there under, ICDR Regulations, Guidance Note and engagement letter, we report that:

a) The "Restated Summary Statement of Assets and Liabilities" as set out in Annexure 1 to this report, of the Company as at 31st March 2025, 31st March 2024 and 31st March 2023 are prepared by the Company and approved by the Board of Directors. These Restated Summary Statements of Assets and Liabilities, have been arrived at after making such adjustments and regroupings to the individual financial statements of the Company, as in our opinion were appropriate and more fully described in Significant Accounting Policies and Notes to Accounts as set out in Annexure 41 to this Report.

b) The "Restated Summary Statement of Profit and Loss" as set out in Annexure 2 to this report, of the Company for the financial year ended on 31st March 2025, 31st March 2024, and 31st March 2023 are prepared by the Company and approved by the Board of Directors. These Restated summary Statement of Profit and Loss have been arrived at after making such adjustments and regroupings to the individual financial statements of the Company, as in our opinion were appropriate and more fully described in Significant Accounting Policies and Notes to Accounts as set out in Annexure 41 to this Report.

c) The "Restated Summary Statement of Cash Flow" as set out in Annexure 3 to this report, of the Company for the financial year ended on 31st March 2025, 31st March 2024, and 31st March 2023 are

prepared by the Company and approved by the Board of Directors. These Restated summary Statement of Cash Flow have been arrived at after making such adjustments and regroupings to the individual financial statements of the Company, as in our opinion were appropriate and more fully described in Significant Accounting Policies and Notes to Accounts as set out in Annexure 41 to this Report.

(iv) We have also examined the following other financial information relating to the Company prepared by the management and as approved by the board of directors of the Company and annexed to this report relating to the Company for the financial year ended on 31st March 2025, 31st March 2024, and 31st March 2023 proposed to be included in the Prospectus ("Offer Document").

Annexure No.

Particulars

1

Restated Statement of Assets & Liabilities

2

Restated Statement of Profit & Loss

3

Restated Statement of Cash Flow

4(A)

Reconciliation of Restated Profit & Audited Profit

4(B)

Reconciliation of Restated Equity & Audited Equity

4(C)

Reconciliation of Restated Revenue & Audited Revenue

5

Restated Statement of Share Capital

6

Restated Statement of Reserve & Surplus

7

Restated Statement of Long Term Borrowings

8

Restated Statement of Deferred Tax Liability

9

Restated Statement of Other Long Term Liabilities

10

Restated Statement of Long Term Provisions

11

Restated Statement of Short Term Borrowings

12

Restated Statement of Trade Payables

13

Restated Statement of Other Current Liabilities

14

Restated Statement of Short Term Provisions

15

Restated Statement of Property Plant & Equipment

16

Restated Statement of Non-Current Investment

17

Restated Statement of Inventories

18

Restated Statement of Trade Receivables

19

Restated Statement of Cash & Cash Equivalent

20

Restated Statement of Short Term Loan & Advances

21

Restated Statement of Other Current Assets

22

Restated Statement of Revenue from Operation

23

Restated Statement of Other Income

24

Restated Statement of Purchase of Stock in Trade

25

Restated Statement of Change in Inventories of FG, Stock-In-Trade

26

Restated Statement of Employee Benefit Expenses

27

Restated Statement of Finance Costs

28

Restated Statement of Depreciation & Amortization Expenses

29

Restated Statement of Other Expenses

30

Restated Statement of Accounting Ratios

31

Restated Statement of Related Party Transactions

32

Restated Statement of Segment Reporting

33

Restated Statement of Tax Shelter

34

Restated Statement of Earning Per Share

35

Disclosure in Respect of Gratuity Liability

36

Disclosure in Respect of Audit Fees

 

Annexure No.

Particulars

37

Capital Risk Management

38

Capitalisation Statement

39

Additional Disclosure

40

Ratio

41

Significant Accounting Policy and Notes

(v) We, M/s. B Shroff & Co, Chartered Accountants have been subjected to the peer review process of the Institute of Chartered Accountants of India ("ICAI") and hold a valid peer review certificate issued by the "Peer Review Board" of the ICAI.

(vi) This report should not in any way be construed as a reissuance or re-dating of any of the previous audit reports issued by any other firm of chartered accountants, nor should this report be construed as a new opinion on any of the financial statements referred to herein.

(vii) We have no responsibility to update our report for events and circumstances occurring after the date of the report.

(viii) Our report is intended solely for use of the Board of Directors for inclusion in the Offer Document in connection with the proposed IPO. Our report should not be used, referred to, or distributed for any other purpose except with our prior consent in writing. Accordingly, we do not accept or assume any liability or any duty of care for any other purpose or to any other person to whom this report is shown or into whose hands it may come without our prior consent in writing.

For B Shroff & CO.

Chartered Accountants,

Firm Registration No: 006514W

Sd/-

CA Manan Agrawal

Partner M No. 418874 FRN: 006514W

UDIN: 25418874BMNWXJ6436

Date: September 19, 2025

Place: Nagpur

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Reg. No. INM000010940, SEBI RA Regn. No: INH000000248, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.